Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction
- 9 October 2000
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 96 (5) , 604-615
- https://doi.org/10.1002/1096-8628(20001009)96:5<604::aid-ajmg5>3.0.co;2-f
Abstract
The human mu opioid receptor (MOR) plays a central role in mediating the effects of opioids, both endogenous and exogenous. Epidemiological studies have shown that addiction in general, and especially opiate addiction, has a heritable component. Clinical and laboratory studies suggest that the MOR gene may contribute to the heritable component of vulnerability to develop opiate addiction. Naturally occurring single nucleotide polymorphisms (SNPs) have been identified in the MOR gene by conventional methods. Two coding region SNPs, the A118G and C17T substitutions, occur at high allelic frequencies (10.5% and 6.6%, respectively, in our previous studies). These common SNPs cause amino acid changes in the receptor, and may have implications for differences in individual responses to opioids, as well as decreased or increased vulnerability to opiate addiction. The A118G substitution encodes a variant receptor with binding and signal transduction differences in response to β-endorphin in cellular assays. Recent innovations in microchip technology offer new potential methods for SNP detection. We report here on the development of two separate approaches using custom oligonucleotide gelpad microarrays for detection of these two common SNPs of the MOR gene in human DNA samples. First, PCR-amplified genomic DNA samples were used to produce target sequences, which were labeled with fluorescent dye and hybridized to custom microchips. Oligonucleotides on these reusable microchips were designed to query nucleotide substitutions at positions 17 and 118 of the MOR gene. Thirty-six human DNA samples were assayed both on these custom microchips and by conventional automated gel sequencing, with highly concordant identification of both heterozygous and homozygous substitutions. A second approach was developed for the C17T SNP utilizing single nucleotide extension on custom microchips. These custom gelpad microchips have potential for the rapid and inexpensive detection of specific SNPs for genetic and genomic studies. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:604–615, 2000.Keywords
This publication has 81 references indexed in Scilit:
- Familial Transmission of Substance Dependence: Alcohol, Marijuana, Cocaine, and Habitual SmokingArchives of General Psychiatry, 1998
- Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addictionProceedings of the National Academy of Sciences, 1998
- μ opioid receptor gene variants: lack of association with alcohol dependenceMolecular Psychiatry, 1997
- Human mu opioid receptor gene polymorphisms and vulnerability to substance abuseAddiction Biology, 1997
- Effect of Chronic Cocaine Treatment on μ‐ and δ‐Opioid Receptor mRNA Levels in Dopaminergically Innervated Brain RegionsJournal of Neurochemistry, 1996
- Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred micePsychiatric Genetics, 1996
- Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/ and DBA/2 strainsLife Sciences, 1995
- Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brainFEBS Letters, 1994
- Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strainsNature Genetics, 1994
- Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred MiceaAnnals of the New York Academy of Sciences, 1992